Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?

被引:0
作者
Melotti, Laura [1 ,2 ]
Rinaldi, Matteo [1 ,3 ]
Salice, Marco [2 ]
Dussias, Nikolas K. [1 ,2 ]
Vanigli, Nicholas [1 ,2 ]
Calabrese, Carlo [1 ,2 ]
Scaioli, Eleonora [2 ]
Gabrielli, Liliana [1 ,4 ]
Lazzarotto, Tiziana [1 ,4 ]
Rosini, Francesca [5 ]
Viale, Pierluigi [1 ,3 ]
Gionchetti, Paolo [1 ,2 ]
Giannella, Maddalena [1 ,3 ]
Rizzello, Fernando [1 ,2 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] IRCCS Azienda Osped Univ Policlin St Orsola Malpig, Dept Med & Surg Sci, IBD Unit, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Dept Integrated Risk Management, Infect Dis Unit, Bologna, Italy
[4] IRCCS Azienda Osped Univ Bologna, Microbiol Unit, Bologna, Italy
[5] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Bologna, Italy
关键词
CMV colitis; inflammatory bowel diseases; colectomy; INFLAMMATORY-BOWEL-DISEASE; CYTOMEGALOVIRUS-INFECTION; REACTIVATION; PREVALENCE; DIAGNOSIS; MODERATE; RISK;
D O I
10.1128/spectrum.01159-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytomegalovirus (CMV) colitis is a serious concern worsening the prognosis of patients with ulcerative colitis (UC). We aimed to assess risk factors and prognostic impact of CMV colitis in patients with moderate-to-severe UC flare. We conducted a retrospective, observational, single-center study. Consecutive adult patients hospitalized for moderate-to-severe UC from January 2020 to June 2023 were included. The primary endpoint was a diagnosis of CMV-colitis according to immunohistochemistry on tissue biopsies. The secondary endpoint was the need for colectomy within 30 days. Overall, 135 patients were included. CMV colitis was diagnosed in n = 37 (27.4%): n = 19 (51.4%) endoscopically, the remaining on surgical specimens. Of them, n = 23 (62.2%) had positive CMV-DNAemia with a median value of 1,008 cp/mL (interquartile range 318-2,980). Differences between the two groups (CMV colitis vs non-CMV) included age (60 vs 41 years, P = 0.004), Charlson Comorbidity Index (1 vs 0, P = 0.003), steroid refractoriness (86.5% vs 62.2%, P = 0.007), and positive CMV-DNAemia (62.2% vs 10.1%, P < 0.001). At multivariable analysis, steroid-refractory disease, Charlson Comorbidity Index, and CMV-DNAemia were associated with CMV colitis. Overall, n = 54 (39.7%) patients underwent colectomy, and this was significantly more common in patients with CMV colitis vs non-CMV group (54.1% vs 34.4%, P = 0.049). Kaplan-Meier showed that antiviral therapy seems to have a relevant impact on colectomy (P < 0.001). CMV-DNA blood detection is independently associated with CMV-positive refractory UC. Since CMV colitis may increase the risk of colectomy and antiviral treatment seems to reduce such risk, prospective studies are needed to confirm the role of CMV-DNA blood detection to early diagnose CMV colitis. IMPORTANCE Cytomegalovirus (CMV) colonic reactivation worsens the prognosis of patients with active ulcerative colitis. Blood CMV-DNA reactivation is strongly associated with CMV colitis. Prompt diagnosis and treatment of CMV colitis can avoid surgery in most cases.
引用
收藏
页数:10
相关论文
共 25 条
[1]   Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis [J].
Beswick, Lauren ;
Ye, Bei ;
van Langenberg, Daniel R. .
INFLAMMATORY BOWEL DISEASES, 2016, 22 (12) :2966-2976
[2]   Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience [J].
Bonta, Jonas ;
Zeitz, Jonas ;
Frei, Pascal ;
Biedermann, Luc ;
Sulz, Michael C. ;
Vavricka, Stephan R. ;
Scharl, Sylvie ;
Fried, Michael ;
Rogler, Gerhard ;
Scharl, Michael .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (11) :1329-1334
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]  
Cohen S, 2018, PEDIATR INFECT DIS J, V37, P197, DOI [10.1097/INF.0000000000001724, 10.1097/inf.0000000000001724]
[5]   Cytomegalovirus Infection in Ulcerative Colitis: A Prospective, Comparative Study on Prevalence and Diagnostic Strategy [J].
Domenech, Eugeni ;
Vega, Roser ;
Ojanguren, Isabel ;
Hernandez, Agueda ;
Garcia-Planella, Esther ;
Bernal, Isabel ;
Rosinach, Merce ;
Boix, Jaume ;
Cabre, Eduard ;
Gassull, Miquel A. .
INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) :1373-1379
[6]   Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease [J].
Gionchetti, Paolo ;
Rizzello, Fernando ;
Annese, Vito ;
Armuzzi, Alessandro ;
Biancone, Livia ;
Castiglione, Fabiana ;
Comberlato, Michele ;
Cottone, Mario ;
Danese, Silvio ;
Daperno, Marco ;
D'Inca, Renata ;
Fries, Walter ;
Kohn, Anna ;
Orlando, Ambrogio ;
Papi, Claudio ;
Vecchi, Maurizio ;
Ardizzone, Sandro .
DIGESTIVE AND LIVER DISEASE, 2017, 49 (06) :604-617
[7]   Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis [J].
Kim, Jong Wook ;
Boo, Sun-Jin ;
Ye, Byong Duk ;
Kim, Chang Lae ;
Yang, Suk-Kyun ;
Kim, Jihun ;
Kim, Sun A. ;
Park, Sang Hyoung ;
Park, Soo-Kyung ;
Yang, Dong-Hoon ;
Jung, Kee Wook ;
Kim, Kyung-Jo ;
Byeon, Jeong-Sik ;
Myung, Seung-Jae ;
Kim, Jin-Ho .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (07) :693-701
[8]   Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study [J].
Kim, You Sun ;
Kim, Young-Ho ;
Kim, Joo Sung ;
Jeong, Seong Yeon ;
Park, Soo Jeong ;
Cheon, Jae Hee ;
Ye, Byong Duk ;
Jung, Sung-Ae ;
Park, Young Sook ;
Choi, Chang Hwan ;
Kim, Kyeung Ok ;
Jang, Byung Ik ;
Han, Dong Soo ;
Yang, Suk-Kyun ;
Kim, Won Ho .
GUT AND LIVER, 2014, 8 (06) :643-647
[9]   Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome [J].
Kishore, J ;
Ghoshal, U ;
Ghoshal, UC ;
Krishnani, N ;
Kumar, S ;
Singh, M ;
Ayyagari, A .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (11) :1155-1160
[10]   ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease (Publication with Expression of Concern) [J].
Kucharzik, T. ;
Ellul, P. ;
Greuter, T. ;
Rahier, J. F. ;
Verstockt, B. ;
Abreu, C. ;
Albuquerque, A. ;
Allocca, M. ;
Esteve, M. ;
Farraye, F. A. ;
Gordon, H. ;
Karmiris, K. ;
Kopylov, U. ;
Kirchgesner, J. ;
MacMahon, E. ;
Magro, F. ;
Maaser, C. ;
de Ridder, L. ;
Taxonera, C. ;
Toruner, M. ;
Tremblay, L. ;
Scharl, M. ;
Viget, N. ;
Zabana, Y. ;
Vavricka, S. .
JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) :879-913